Relevance of TP53 for CLL diagnosticsMark A Catherwood, David Gonzalez, David Donaldson, Ruth Clifford, Ken Mills, Patrick Thornton
2 February 2019
Circulating tumour DNA, microRNA and metabolites in cerebrospinal fluid as biomarkers for central nervous system malignanciesSoheil Zorofchian, Fatima Iqbal, Mayank Rao, Phyu P Aung, Yoshua Esquenazi, Leomar Y Ballester
22 November 2018
Microvessel density in breast cancer: the impact of field area on prognostic informativenessMaria Ryssdal Kraby, Signe Opdahl, Hege Giercksky Russnes, Anna M Bofin
10 January 2019
Revitalising an academic pathology department: lessons learntZu-hua Gao, Edith Zorychta, Jason Karamchandani, René P Michel, Fadi Brimo, Carlos Telleria, Sophie Camilleri-Broët, Manon Auger, Van-Hung Nguyen, Alan Spatz
22 November 2018
RAS genes in colorectal carcinoma: pathogenesis, testing guidelines and treatment implicationsOmer Saeed, Antonio Lopez-Beltran, Kurt W Fisher, Marina Scarpelli, Rodolfo Montironi, Alessia Cimadamore, Francesco Massari, Matteo Santoni, Liang Cheng
13 November 2018
HbA1c: a review of non-glycaemic variablesLeon Campbell, Tessa Pepper, Kate Shipman
25 October 2018
Setting up a service for a faecal immunochemical test for haemoglobin (FIT): a review of considerations, challenges and constraintsIan M Godber, Sally C Benton, Callum G Fraser
1 October 2018
CDK12: an emerging therapeutic target for cancerGoldie Y L Lui, Carla Grandori, Christopher J Kemp
13 August 2018
p16Stefano Serra, Runjan Chetty
3 August 2018
A review on the Idylla platform: towards the assessment of actionable genomic alterations in one dayArnaud Uguen, Giancarlo Troncone
14 June 2018